Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
CLEVELAND, Ohio -- The damage that diabetes wreaks on young bodies isn't always obvious, although children as young as 7 can have brownish-gray patches on their necks or elbows that are early predictors of the condition.
But a clinical trial that started in November at University Hospitals Rainbow Babies & Children's Hospital is using a new device to get ahead of the visual clues the skin can offer.
The noninvasive light device, SCOUT-DS by VeraLight, an Albuquerque, N.M.-based company, identifies biochemical markers of diabetes -- Skin Advanced Glycation End Products, or SAGES for short -- in the skin of children or teens.
http://www.cleveland.com/healthfit/index.ssf/2013/01/rainbow_studies_early_non-inva.html
But a clinical trial that started in November at University Hospitals Rainbow Babies & Children's Hospital is using a new device to get ahead of the visual clues the skin can offer.
The noninvasive light device, SCOUT-DS by VeraLight, an Albuquerque, N.M.-based company, identifies biochemical markers of diabetes -- Skin Advanced Glycation End Products, or SAGES for short -- in the skin of children or teens.
http://www.cleveland.com/healthfit/index.ssf/2013/01/rainbow_studies_early_non-inva.html